BRCA1 Mutations May Predict Response to Treatment in Ovarian and Breast Cancers

BRCA1 Mutations May Predict Response to Treatment in Ovarian and Breast Cancers
Specific mutations in the BRCA1 gene may predict poor treatment responses in ovarian and breast cancer, according to two new studies published in The Journal of Clinical Investigation. Mutations in the BRCA1 gene are one of the most common risk factors for hereditary breast and ovarian cancers, as this protein is involved in a number of

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *